Diagnostic Utility of Aldosterone/Direct Renin Concentration Ratio in Iraqi Patients with High Arterial Blood Pressure: A Pilot Study

IF 0.2 Q4 MEDICINE, GENERAL & INTERNAL
Zaid Q. Abd Al-Razaq, Mahmood Shakir Khudhair, Khalid Abdulhussein Sabry
{"title":"Diagnostic Utility of Aldosterone/Direct Renin Concentration Ratio in Iraqi Patients with High Arterial Blood Pressure: A Pilot Study","authors":"Zaid Q. Abd Al-Razaq, Mahmood Shakir Khudhair, Khalid Abdulhussein Sabry","doi":"10.22317/jcms.v9i4.1398","DOIUrl":null,"url":null,"abstract":"
 
 
 Objectives: Primary aldosteronism is a prevalent contributor to secondary hypertension, posing an elevated risk of morbidity and mortality. The initial step in diagnosing this condition involves screening individuals suspected of having it.
 Methods: In our study, we enrolled 50 patients who were suspected of having hyperaldosteronism. We provided specific recommendations and instructions to these patients concerning drug therapy and implemented measures to enhance testing accuracy. The tests were conducted using the Chemiluminescence Immunoassay (CLIA) system procedure, relying on plasma direct renin concentration rather than activity. Our findings were meticulously validated, compared, and aligned with the references from ARUP laboratories.
 Results: Among our participants, 4 patients (8%) were unequivocally diagnosed with primary aldosteronism based on the Aldosterone Direct Renin Concentration (ADRR) criteria. These patients exhibited the trifecta of hypokalemia, elevated aldosterone levels, and diminished renin levels, obviating the need for further confirmatory testing. Furthermore, 13 patients (26%) were deemed likely candidates for primary aldosteronism, given their plasma aldosterone levels exceeding 15 ng/dl and renin levels below 2.5 pg/ml. Additionally, 7 patients (14%) displayed strong indications of primary aldosteronism, characterized by plasma aldosterone levels surpassing 21 ng/dl and plasma renin concentrations below 2.5 pg/ml, accompanied by high ADRR values. However, both the \"likely\" and \"strong indication\" groups necessitated confirmatory testing. Notably, our results revealed no significant disparities in age, gender, personal or family history of atherosclerotic cardiovascular disease (ASCVD), or the presence of adrenal adenomas between patients diagnosed with primary aldosteronism and those in the non-aldosteronism group within the study.
 Conclusion: Primary aldosteronism is a prevalent health concern, warranting the screening of highly suspicious patients. Utilizing direct renin concentration, instead of renin activity, offers a straightforward, cost-effective, rapid, and reproducible method for diagnosis.
 
 
","PeriodicalId":42860,"journal":{"name":"Journal of Contemporary Medical Sciences","volume":"29 1","pages":"0"},"PeriodicalIF":0.2000,"publicationDate":"2023-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Contemporary Medical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22317/jcms.v9i4.1398","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Primary aldosteronism is a prevalent contributor to secondary hypertension, posing an elevated risk of morbidity and mortality. The initial step in diagnosing this condition involves screening individuals suspected of having it. Methods: In our study, we enrolled 50 patients who were suspected of having hyperaldosteronism. We provided specific recommendations and instructions to these patients concerning drug therapy and implemented measures to enhance testing accuracy. The tests were conducted using the Chemiluminescence Immunoassay (CLIA) system procedure, relying on plasma direct renin concentration rather than activity. Our findings were meticulously validated, compared, and aligned with the references from ARUP laboratories. Results: Among our participants, 4 patients (8%) were unequivocally diagnosed with primary aldosteronism based on the Aldosterone Direct Renin Concentration (ADRR) criteria. These patients exhibited the trifecta of hypokalemia, elevated aldosterone levels, and diminished renin levels, obviating the need for further confirmatory testing. Furthermore, 13 patients (26%) were deemed likely candidates for primary aldosteronism, given their plasma aldosterone levels exceeding 15 ng/dl and renin levels below 2.5 pg/ml. Additionally, 7 patients (14%) displayed strong indications of primary aldosteronism, characterized by plasma aldosterone levels surpassing 21 ng/dl and plasma renin concentrations below 2.5 pg/ml, accompanied by high ADRR values. However, both the "likely" and "strong indication" groups necessitated confirmatory testing. Notably, our results revealed no significant disparities in age, gender, personal or family history of atherosclerotic cardiovascular disease (ASCVD), or the presence of adrenal adenomas between patients diagnosed with primary aldosteronism and those in the non-aldosteronism group within the study. Conclusion: Primary aldosteronism is a prevalent health concern, warranting the screening of highly suspicious patients. Utilizing direct renin concentration, instead of renin activity, offers a straightforward, cost-effective, rapid, and reproducible method for diagnosis.
醛固酮/直接肾素浓度比在伊拉克高血压患者中的诊断价值:一项初步研究
& # x0D;& # x0D;& # x0D;目的:原发性醛固酮增多症是继发性高血压的一个普遍因素,其发病率和死亡率增高。诊断这种疾病的第一步是对疑似患有这种疾病的人进行筛查。方法:在我们的研究中,我们招募了50名被怀疑患有高醛固酮增多症的患者。我们对这些患者在药物治疗方面提供了具体的建议和指导,并采取措施提高检测的准确性。使用化学发光免疫测定(CLIA)系统程序进行测试,依赖于血浆直接肾素浓度而不是活性。我们的研究结果经过了仔细的验证、比较,并与ARUP实验室的参考文献保持一致。结果:在我们的参与者中,4例患者(8%)根据醛固酮直接肾素浓度(ADRR)标准明确诊断为原发性醛固酮增多症。这些患者表现出低钾血症、醛固酮水平升高和肾素水平降低的三重症状,因此不需要进一步的确证检测。此外,13名患者(26%)被认为可能是原发性醛固酮增多症的候选者,因为他们的血浆醛固酮水平超过15 ng/dl,肾素水平低于2.5 pg/ml。此外,7例患者(14%)表现出原发性醛固酮增多症的强烈适应症,其特征是血浆醛固酮水平超过21 ng/dl,血浆肾素浓度低于2.5 pg/ml,并伴有高adr值。然而,“可能”和“强指征”两组都需要进行确认性检测。值得注意的是,我们的研究结果显示,在年龄、性别、动脉粥样硬化性心血管疾病(ASCVD)的个人或家族史或肾上腺腺瘤的存在方面,原发性醛固酮增多症患者与研究中非醛固酮增多症患者之间没有显著差异。 结论:原发性醛固酮增多症是一种普遍的健康问题,需要对高度可疑的患者进行筛查。利用直接肾素浓度,而不是肾素活性,提供了一种简单、经济、快速和可重复的诊断方法。 & # x0D;& # x0D;
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Contemporary Medical Sciences
Journal of Contemporary Medical Sciences MEDICINE, GENERAL & INTERNAL-
自引率
0.00%
发文量
65
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信